Effects of Doramectin on Cholangiocarcinoma Cells
Author Information
Author(s): Zhang Yunfang, Wu Wei, Shi Yan, Huang Yuehong, Dai Ting, Ke Lina, Chen Lizhu, Chen Mingliang, Wang Qin
Primary Institution: Xiamen University
Hypothesis
Doramectin inhibits the viability of human cholangiocarcinoma cells (Mz-ChA-1) through specific mechanisms.
Conclusion
Doramectin effectively suppresses the growth and proliferation of Mz-ChA-1 cells and induces apoptosis.
Supporting Evidence
- Doramectin treatment reduced the viability of Mz-ChA-1 cells in a dose-dependent manner.
- The IC50 values for Mz-ChA-1 cells were determined to be 12.16 μmol/L and 7.613 μmol/L at 24 h and 48 h, respectively.
- Doramectin induced apoptosis in Mz-ChA-1 cells, evidenced by increased levels of cleaved caspase 3 and PARP1.
- Cell cycle analysis showed that Doramectin caused G1 phase arrest in Mz-ChA-1 cells.
- Doramectin significantly inhibited the migration and invasion abilities of Mz-ChA-1 cells.
Takeaway
Doramectin is a drug that can help stop cancer cells from growing and can make them die.
Methodology
The study involved treating Mz-ChA-1 cells with different concentrations of Doramectin and analyzing cell viability, migration, invasion, and apoptosis through various assays.
Limitations
The study primarily focused on in vitro models, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website